SCHEMBL1089294

SCHEMBL1089294

O=C(c1cccc(F)c1)N1CCC(N2CCC(Nc3nccc(N4CCCCCC4)n3)C2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.54
HTT P42858 1/20 0.49
CXCR4 P61073 1/20 0.47
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 2/20 0.46
EPHX2 P34913 1/20 0.46
L3MBTL3 Q96JM7 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MBTD1 Q05BQ5 1/20 0.43
CYP3A4 P08684 2/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP2D6 P10635 1/20 0.42
HPGD P15428 1/20 0.42
CCNK O75909 2/20 0.42
CDK12 Q9NYV4 2/20 0.42
ABL1 P00519 1/20 0.42
BCR P11274 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089111 0.96 TDP1 (0.58) TDP1HTTCXCR4ALDH1A1KDM4E
SCHEMBL1090534 0.96 TDP1 (0.55) TDP1HTTCXCR4ALDH1A1KDM4E
SCHEMBL1090070 0.96 TDP1 (0.58) TDP1HTTCXCR4ALDH1A1KDM4E
SCHEMBL1090686 0.92 HTT (0.48) TDP1HTTCXCR4ALDH1A1EPHX2
SCHEMBL1090983 0.90 GBA1 (0.49) CXCR4KDM4EEPHX2L3MBTL3L3MBTL1
SCHEMBL1090198 0.90 MEN1 (0.52) CXCR4ALDH1A1KDM4EL3MBTL3L3MBTL1
SCHEMBL1089223 0.90 L3MBTL1 (0.53) CXCR4ALDH1A1KDM4EEPHX2L3MBTL3
SCHEMBL1091044 0.90 CXCR4 (0.56) TDP1CXCR4ALDH1A1KDM4EL3MBTL3
SCHEMBL1089128 0.89 CCNK (0.48) TDP1HTTCXCR4ALDH1A1EPHX2
SCHEMBL1090511 0.88 HTT (0.49) TDP1HTTCXCR4ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 TDP1 3801/4885HTT 3256/4885CXCR4 1/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 TDP1 3801/4885HTT 3256/4885CXCR4 1/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 TDP1 3801/4885HTT 3256/4885CXCR4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.